| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
3 companies
Greenleaf Peter is a Chief Executive Officer at Aurinia Pharmaceuticals Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 3 buys and 5 sells.
Estimated insider holdings value: $34.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Chief Executive Officer | Sell | 360,540 | $7.96 | $2,871,124.24 | -8.8% | -1.5% | +86.1% | |
| Mar 6, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Chief Executive Officer | Sell | 126,981 | $5.60 | $711,093.60 | -7.7% | -4.5% | +48.4% | |
| Mar 2, 2023 | AUPH Aurinia Pharmaceuticals Inc. | Chief Executive Officer | Sell | 32,750 | $8.94 | $292,785.00 | -3.2% | +0.2% | -35.3% | |
| Mar 2, 2022 | AUPH Aurinia Pharmaceuticals Inc. | Chief Executive Officer | Sell | 9,068 | $12.01 | $108,906.68 | -21.6% | -2.9% | -23.1% | |
| May 11, 2021 | AUPH Aurinia Pharmaceuticals Inc. | Chief Executive Officer | Buy | 5,125 | $10.71 | $54,891.07 | +27.3% | +39.7% | -14.7% | |
| May 18, 2018 | AVTX Avalo Therapeutics, Inc. | Chief Executive Officer | Buy | 12,500 | $3.98 | $49,750.00 | +3.1% | - | - |